SMILE CARE

Basma Adeem Medical Co.

9626StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Operations
Operating Cash Flow	11.37M	7.98M	5.21M	7.04M
Free Cash Flow	4.76M	6.66M	4.07M	5.24M
Capital Expenditures	-6.61M	-1.32M	-1.14M	-1.80M
Investing & Financing
Investing Cash Flow	-6.56M	-1.32M	-1.14M	-1.80M
Financing Cash Flow	14.50M	5.27M	-1.11M	-4.23M
Dividends Paid	—	—	—	-3.60M
Operating Activities
Operating Cash Flow	11.37M	7.98M	5.21M	7.04M
Net Income	7.30M	6.30M	4.87M	3.78M
Change in Accounts Payable	0.63M	-0.09M	-0.43M	2.41M
Change in Accounts Receivable	—	—	—	-79.76K
Change in Inventory	12.50K	-594.41K	-473.36K	-124.14K
Change in Other Net Operating Assets	-566.61K	368.02K	-266.23K	—
Change in Working Capital	0.08M	-0.31M	-1.17M	2.20M
Other Operating Activities	1.31M	0.74M	0.34M	0.28M
Depreciation & Amortization	2.71M	1.25M	1.17M	0.77M
Investing Activities
Investing Cash Flow	-6.56M	-1.32M	-1.14M	-1.80M
Capital Expenditures	-6.61M	-1.32M	-1.14M	-1.80M
Sale of Property, Plant & Equipment	46.00K	—	—	—
Loss (Gain) From Sale of Assets	-35.44K	—	—	—
Financing Activities
Financing Cash Flow	14.50M	5.27M	-1.11M	-4.23M
Common Dividends Paid	—	—	—	-3.60M
Issuance of Common Stock	16.53M	6.50M	—	—
Long-Term Debt Repaid	-2.04M	-1.23M	-1.11M	-0.63M
Net Debt Issued (Repaid)	-2.04M	-1.23M	-1.11M	-0.63M
Free Cash Flow & Returns
Free Cash Flow	4.76M	6.66M	4.07M	5.24M
Free Cash Flow Growth	-28.5%	+63.7%	-22.3%	—
Free Cash Flow Margin	+10.5%	+19.6%	+15.3%	+23.9%
Free Cash Flow Per Share	0.26	0.58	0.43	—
Levered Free Cash Flow	1.19M	4.45M	2.21M	—
Unlevered Free Cash Flow	1.68M	4.66M	2.44M	—
Operating Cash Flow Growth	+42.5%	+53.2%	-26.0%	—
Net Cash Flow	19.30M	11.93M	2.96M	1.01M

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Operations
Operating Cash Flow	11.37M	7.98M	5.21M	7.04M
Free Cash Flow	4.76M	6.66M	4.07M	5.24M
Capital Expenditures	-6.61M	-1.32M	-1.14M	-1.80M
Investing & Financing
Investing Cash Flow	-6.56M	-1.32M	-1.14M	-1.80M
Financing Cash Flow	14.50M	5.27M	-1.11M	-4.23M
Dividends Paid	—	—	—	-3.60M
Operating Activities
Operating Cash Flow	11.37M	7.98M	5.21M	7.04M
Net Income	7.30M	6.30M	4.87M	3.78M
Change in Accounts Payable	0.63M	-0.09M	-0.43M	2.41M
Change in Accounts Receivable	—	—	—	-79.76K
Change in Inventory	12.50K	-594.41K	-473.36K	-124.14K
Change in Other Net Operating Assets	-566.61K	368.02K	-266.23K	—
Change in Working Capital	0.08M	-0.31M	-1.17M	2.20M
Other Operating Activities	1.31M	0.74M	0.34M	0.28M
Depreciation & Amortization	2.71M	1.25M	1.17M	0.77M
Investing Activities
Investing Cash Flow	-6.56M	-1.32M	-1.14M	-1.80M
Capital Expenditures	-6.61M	-1.32M	-1.14M	-1.80M
Sale of Property, Plant & Equipment	46.00K	—	—	—
Loss (Gain) From Sale of Assets	-35.44K	—	—	—
Financing Activities
Financing Cash Flow	14.50M	5.27M	-1.11M	-4.23M
Common Dividends Paid	—	—	—	-3.60M
Issuance of Common Stock	16.53M	6.50M	—	—
Long-Term Debt Repaid	-2.04M	-1.23M	-1.11M	-0.63M
Net Debt Issued (Repaid)	-2.04M	-1.23M	-1.11M	-0.63M
Free Cash Flow & Returns
Free Cash Flow	4.76M	6.66M	4.07M	5.24M
Free Cash Flow Growth	-28.5%	+63.7%	-22.3%	—
Free Cash Flow Margin	+10.5%	+19.6%	+15.3%	+23.9%
Free Cash Flow Per Share	0.26	0.58	0.43	—
Levered Free Cash Flow	1.19M	4.45M	2.21M	—
Unlevered Free Cash Flow	1.68M	4.66M	2.44M	—
Operating Cash Flow Growth	+42.5%	+53.2%	-26.0%	—
Net Cash Flow	19.30M	11.93M	2.96M	1.01M